Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Ingvar

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Springerplus|June 4, 2014
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early eventsMaria Simonsson, Andrea Markkula, Pär-Ola Bendahl, et al.
Acta Dermato-Venereologica|October 31, 2019
Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied DiseaseÅsa M Ingvar, Håkan Olsson, Per Broberg, et al.
Springerplus|February 26, 2014
Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptorUlrik Narbe, Pär-Ola Bendahl, Dorthe Grabau, et al.
Acta Oncologica (Stockholm, Sweden)|May 27, 2010
Natural remedy use in a prospective cohort of breast cancer patients in southern SwedenMaria Hietala, Maria Henningson, Christian Ingvar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 9, 2023
Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patientsJohan Lyth, Rasmus Mikiver, Kari Nielsen, et al.
Melanoma Research|June 8, 2010
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotypeKari Nielsen, Katja Harbst, Anna Måsbäck, et al.
Cancer Letters|September 29, 2007
Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanomaKarin Broberg, Mattias Höglund, Cecilia Gustafsson, et al.
Annals of Surgery|December 25, 2007
Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort StudyLeif Bergkvist, Jana de Boniface, Per-Ebbe Jönsson, et al.
Breast Cancer Research and Treatment|January 6, 2015
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment responseLouise Huzell, Mia Persson, Maria Simonsson, et al.
JAMA|June 24, 2015
Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant MelanomaStacy Loeb, Yasin Folkvaljon, Mats Lambe, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Springerplus|June 4, 2014
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early eventsMaria Simonsson, Andrea Markkula, Pär-Ola Bendahl, et al.
Acta Dermato-Venereologica|October 31, 2019
Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied DiseaseÅsa M Ingvar, Håkan Olsson, Per Broberg, et al.
Springerplus|February 26, 2014
Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptorUlrik Narbe, Pär-Ola Bendahl, Dorthe Grabau, et al.
Acta Oncologica (Stockholm, Sweden)|May 27, 2010
Natural remedy use in a prospective cohort of breast cancer patients in southern SwedenMaria Hietala, Maria Henningson, Christian Ingvar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 9, 2023
Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patientsJohan Lyth, Rasmus Mikiver, Kari Nielsen, et al.
Melanoma Research|June 8, 2010
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotypeKari Nielsen, Katja Harbst, Anna Måsbäck, et al.
Cancer Letters|September 29, 2007
Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanomaKarin Broberg, Mattias Höglund, Cecilia Gustafsson, et al.
Annals of Surgery|December 25, 2007
Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort StudyLeif Bergkvist, Jana de Boniface, Per-Ebbe Jönsson, et al.
Breast Cancer Research and Treatment|January 6, 2015
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment responseLouise Huzell, Mia Persson, Maria Simonsson, et al.
JAMA|June 24, 2015
Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant MelanomaStacy Loeb, Yasin Folkvaljon, Mats Lambe, et al.
Pageof 15